Genomic data can improve safety assessments by providing insights into the genetic factors that influence an individual's response to toxic exposure. By incorporating genomic analysis into risk assessments, scientists can predict potential adverse effects more accurately and identify populations at higher risk. This approach can lead to more targeted and efficient regulatory decisions, ultimately enhancing public health protection.
